MEP51608A - Pulverulent formulation for inhalation containing tiotropium - Google Patents

Pulverulent formulation for inhalation containing tiotropium

Info

Publication number
MEP51608A
MEP51608A MEP-516/08A MEP51608A MEP51608A ME P51608 A MEP51608 A ME P51608A ME P51608 A MEP51608 A ME P51608A ME P51608 A MEP51608 A ME P51608A
Authority
ME
Montenegro
Prior art keywords
containing tiotropium
inhalation containing
formulation
pulverulent formulation
pulverulent
Prior art date
Application number
MEP-516/08A
Other languages
English (en)
Croatian (hr)
Inventor
Mareke Hartig
Michael Trunk
Michael Walz
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP51608(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP51608A publication Critical patent/MEP51608A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pronalazak se odnosi na formulaciju praha za inhaliranje koje sadrže tiotropijum, na postupak za njihovo pripremanje kao i na njihovu primjenu za pripremanje lijeka za liječenje oboljenja disajnih puteva, naročito za tretiranje COPD-a (chronic obstrucitive pulmonary disease=hronično opstruktivno oboljenje pluća) i astme.
MEP-516/08A 2002-11-28 2003-11-19 Pulverulent formulation for inhalation containing tiotropium MEP51608A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (de) 2002-11-28 2002-11-28 Neue Tiotropium-haltige Pulverformulierung für die Inhalation
PCT/EP2003/012911 WO2004047796A2 (de) 2002-11-28 2003-11-19 Neue tiotropium-haltige pulverformulierung für die inhalation

Publications (1)

Publication Number Publication Date
MEP51608A true MEP51608A (en) 2011-02-10

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-516/08A MEP51608A (en) 2002-11-28 2003-11-19 Pulverulent formulation for inhalation containing tiotropium

Country Status (34)

Country Link
EP (1) EP1567135B1 (bs)
JP (1) JP4977321B2 (bs)
KR (1) KR101066805B1 (bs)
CN (1) CN100574751C (bs)
AR (1) AR042242A1 (bs)
AT (1) ATE401861T1 (bs)
AU (1) AU2003294714B2 (bs)
BR (1) BR0316343A (bs)
CA (1) CA2507579C (bs)
CO (1) CO5580736A2 (bs)
CY (1) CY1108420T1 (bs)
DE (2) DE10255387A1 (bs)
DK (1) DK1567135T3 (bs)
EA (1) EA011549B1 (bs)
EC (1) ECSP055821A (bs)
ES (1) ES2310681T3 (bs)
HK (1) HK1085918A1 (bs)
HR (1) HRP20050468A2 (bs)
IL (1) IL168810A (bs)
ME (1) MEP51608A (bs)
MX (1) MXPA05005485A (bs)
MY (1) MY140890A (bs)
NO (1) NO20053090L (bs)
PE (1) PE20040848A1 (bs)
PL (1) PL376229A1 (bs)
PT (1) PT1567135E (bs)
RS (1) RS20050400A (bs)
SA (1) SA04240467B1 (bs)
SI (1) SI1567135T1 (bs)
TW (1) TWI332837B (bs)
UA (1) UA81930C2 (bs)
UY (1) UY28096A1 (bs)
WO (1) WO2004047796A2 (bs)
ZA (1) ZA200502859B (bs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102008014025A1 (de) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Sieb für einen Inhalator
TR200909788A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
PE20130601A1 (es) * 2010-08-03 2013-05-30 Chiesi Farma Spa Formulacion de polvo seco que comprende un inhidor de fosfodiesterasa
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
SK284889B6 (sk) * 1998-11-13 2006-02-02 Jago Research Ag Použitie stearátu horečnatého v suchých práškových formuláciách na inhaláciu
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DZ3477A1 (bs) * 2000-10-12 2002-04-18
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
CA2507579C (en) 2011-07-19
JP2006510622A (ja) 2006-03-30
EA011549B1 (ru) 2009-04-28
CA2507579A1 (en) 2004-06-10
TWI332837B (en) 2010-11-11
ES2310681T3 (es) 2009-01-16
PT1567135E (pt) 2008-09-01
TW200500066A (en) 2005-01-01
CN1717225A (zh) 2006-01-04
DK1567135T3 (da) 2008-10-27
SI1567135T1 (sl) 2008-10-31
PE20040848A1 (es) 2005-01-14
CY1108420T1 (el) 2014-04-09
ECSP055821A (es) 2005-08-11
KR20050086887A (ko) 2005-08-30
WO2004047796A2 (de) 2004-06-10
KR101066805B1 (ko) 2011-09-22
CN100574751C (zh) 2009-12-30
NO20053090D0 (no) 2005-06-23
NO20053090L (no) 2005-06-23
AU2003294714A1 (en) 2004-06-18
HRP20050468A2 (en) 2006-07-31
EP1567135A2 (de) 2005-08-31
MY140890A (en) 2010-01-29
CO5580736A2 (es) 2005-11-30
AR042242A1 (es) 2005-06-15
UY28096A1 (es) 2004-06-30
WO2004047796A3 (de) 2004-09-30
DE50310208D1 (de) 2008-09-04
ZA200502859B (en) 2006-02-22
DE10255387A1 (de) 2004-06-09
JP4977321B2 (ja) 2012-07-18
EA200500864A1 (ru) 2006-02-24
ATE401861T1 (de) 2008-08-15
AU2003294714B2 (en) 2009-10-08
RS20050400A (en) 2007-04-10
PL376229A1 (en) 2005-12-27
BR0316343A (pt) 2005-09-27
UA81930C2 (uk) 2008-02-25
EP1567135B1 (de) 2008-07-23
SA04240467B1 (ar) 2008-10-15
MXPA05005485A (es) 2005-07-25
IL168810A (en) 2015-02-26
HK1085918A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
MEP40108A (bs) Novi tiotropijumski preparati – koji sadrže prah za inhaliranje
HRP20050570A2 (en) Powdered medicament for inhalation comprising a tiotropium salt and salmetrol xinafoate
MEP30108A (en) Formoterol superfine formulation
MY155912A (en) New inhalable powder containing tiotropium
HRP20050468A2 (en) Pulverulent formulation for inhalation containing tiotropium
ME00349B (me) Novi kristalni anhidrat sa antiholinergij skim dejstvom
SG149876A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
MEP51308A (bs) Postupak za dobijanje novih soli tiotropijuma, nove soli tiotropijuma kao takve, kao i farmaceutske formulacije koje ih sadrže
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
NO20073909L (no) Forstover-formulering
ATE339951T1 (de) Pulverzubereitungen zur inhalation
CY1113392T1 (el) Νεες κρυσταλλικες μορφες του βρωμιουχου τιοτροπιου
BRPI0415685A (pt) sais de tiotrópio, processos para sua produção, bem como formulações de medicamentos contendo os mesmos